Cubist Systematic Strategies, LLC Biodesix Inc Transaction History
Cubist Systematic Strategies, LLC
- $20.3 Billion
- Q2 2025
A detailed history of Cubist Systematic Strategies, LLC transactions in Biodesix Inc stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 14,346 shares of BDSX stock, worth $97,983. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,346Holding current value
$97,983% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding BDSX
# of Institutions
42Shares Held
35.8MCall Options Held
0Put Options Held
0-
Telemark Asset Management, LLC Boston, MA8.28MShares$56.6 Million0.75% of portfolio
-
Bryn Mawr Trust CO Bryn Mawr, PA6.1MShares$41.6 Million0.03% of portfolio
-
Birchview Capital, LP Burlington, VT5.74MShares$39.2 Million1.69% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.79MShares$25.9 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY2.17MShares$14.8 Million0.03% of portfolio
About BIODESIX INC
- Ticker BDSX
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 39,982,000
- Market Cap $273M
- Description
- Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pat...